← All trials
NCT04327505
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 25, 2020
- Primary completion
- Oct 31, 2021
- Completion date
- Dec 31, 2022
- First posted
- Mar 31, 2020
- Last posted
- Mar 31, 2020
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Karolinska InstituteLead sponsor
- Karolinska InstituteCollaborator
- University of California, San DiegoCollaborator
- Karolinska InstituteReponsible party - principal investigator
- Karolinska InstituteOverall official - principal investigator
- Karolinska InstituteStudy chair
- Blekinge County Council HospitalCollaborator
- The Swedish Research CouncilCollaborator
- JK Biostatistics ABCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.